Paper Details
- Home
- Paper Details
Effects of 26 Recombinant CYP3A4 Variants on Brexpiprazole Metabolism.
Author: CaiJian-Pin, ChenBingbing, ChenDaoxing, HuGuo-Xin, WangShuanghu, WenJian, ZhangBowen, ZhangXiao-Dan
Original Abstract of the Article :
As a new atypical antipsychotic, brexpiprazole is primarily metabolized by cytochrome P450 3A4 (CYP3A4). However, genetic polymorphisms in CYP3A4 cause wide variability in individuals' responses to brexpiprazole, leading to unpredictable adverse side effects or even therapeutic failure. The present ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1021/acs.chemrestox.9b00186
データ提供:米国国立医学図書館(NLM)
Effects of 26 Recombinant CYP3A4 Variants on Brexpiprazole Metabolism
Brexpiprazole, an atypical antipsychotic, is metabolized by cytochrome P450 3A4 (CYP3A4). This study investigates the effects of various CYP3A4 genetic variants on brexpiprazole metabolism. The authors examined the enzymatic activity of 26 recombinant CYP3A4 variants in vitro, comparing their ability to metabolize brexpiprazole to the wild-type enzyme. They discovered that [主要な発見] This study provides valuable insights into the genetic variability in brexpiprazole metabolism and could help guide clinicians in optimizing drug dosages and minimizing adverse effects.
CYP3A4 Variants and Drug Metabolism: A Personalized Approach
This study emphasizes that [社会的な意義] The authors' findings highlight the need for personalized medicine approaches in drug therapy, considering genetic variations that can significantly influence drug metabolism and response.
Brexpiprazole and CYP3A4: A Complex Interaction
This study demonstrates that [健康的なベネフィットもしくはリスク] It's essential to discuss your family history and any relevant genetic factors with your doctor before starting brexpiprazole treatment. This information can help your doctor make informed decisions about appropriate dosage and potential side effects.
Dr.Camel's Conclusion
Imagine the human body as a complex desert ecosystem, with various enzymes playing essential roles in metabolizing medications. This study, like a desert explorer meticulously mapping the terrain, reveals the intricate relationship between CYP3A4 variants and brexpiprazole metabolism. It's a reminder that even seemingly subtle variations in our genes can profoundly impact how our bodies process medications. This research emphasizes the need for personalized medicine approaches to ensure safe and effective drug therapy.
Date :
- Date Completed 2021-01-21
- Date Revised 2021-01-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.